• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用电子捕获气相色谱法测定人血浆中氯伏沙明的浓度。

Determination of clovoxamine concentration in human plasma by electron capture gas chromatography.

作者信息

Hurst H E, Jones D R, Jarboe C H, deBree H

出版信息

Clin Chem. 1981 Jul;27(7):1210-2.

PMID:7237785
Abstract

The antidepressant drug clovoxamine can be specifically and sensitively quantitated in human plasma by electron capture gas chromatography. Clovoxamine and the internal standard fluvoxamine are extracted into ethyl acetate from plasma at pH 12, back-extracted into phosphoric acid, and hydrolyzed at 90 degrees C to form ketone derivatives, which are then re-extracted into hexane for injection into the chromatograph. As little as 1 microgram of clovoxamine per liter of plasma can be measured. The coefficients of variation (CV) for th analysis at concentrations of 10 and 100 micrograms/L are respectively: within-run, 5.4% and 2.7%; between-run, 17.5% and 7.0%. When this assay was applied to plasma from individuals involved in an early clinical trial of clovoxamine, steady-state plasma concentrations ranged from 50 to 77 micrograms/L 3 h after a 50-mg oral dose of clovoxamine fumarate.

摘要

抗抑郁药氯伏胺可通过电子捕获气相色谱法在人血浆中进行特异性和灵敏的定量分析。氯伏胺和内标氟伏沙明在pH 12条件下从血浆中萃取到乙酸乙酯中,再反萃取到磷酸中,并在90℃水解形成酮衍生物,然后再萃取到己烷中注入色谱仪。每升血浆中低至1微克的氯伏胺都能被检测到。在浓度为10和100微克/升时分析的变异系数(CV)分别为:批内,5.4%和2.7%;批间,17.5%和7.0%。当该测定法应用于参与氯伏胺早期临床试验个体的血浆时,口服50毫克富马酸氯伏胺3小时后,稳态血浆浓度范围为50至77微克/升。

相似文献

1
Determination of clovoxamine concentration in human plasma by electron capture gas chromatography.采用电子捕获气相色谱法测定人血浆中氯伏沙明的浓度。
Clin Chem. 1981 Jul;27(7):1210-2.
2
The use of a pre-column for the direct high-performance liquid chromatographic determination of the anti-depressants clovoxamine and fluvoxamine in plasma.使用预柱直接高效液相色谱法测定血浆中的抗抑郁药氯伏沙明和氟伏沙明。
J Chromatogr. 1980 Aug 8;183(2):203-11. doi: 10.1016/s0378-4347(00)81694-1.
3
Clovoxamine kinetics in an early clinical trial.早期临床试验中的氯伏沙明动力学
Clin Pharmacol Ther. 1983 Aug;34(2):266-71. doi: 10.1038/clpt.1983.164.
4
Fluorimetric determination of fluvoxamine or clovoxamine in human plasma after thin-layer chromatographic or high-performance liquid chromatographic separation.
J Chromatogr. 1986 Oct 31;382:405-11. doi: 10.1016/s0378-4347(00)83552-5.
5
Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
J Neural Transm. 1980;49(1-2):63-86. doi: 10.1007/BF01249190.
6
High performance liquid chromatographic determination of fluvoxamine in human plasma.高效液相色谱法测定人血浆中的氟伏沙明
Biomed Chromatogr. 1989 Jul;3(4):177-9. doi: 10.1002/bmc.1130030408.
7
Chronic treatment with fluvoxamine, clovoxamine, and placebo: interaction with digoxin and effects on sleep and alertness.氟伏沙明、氯伏沙明及安慰剂的长期治疗:与地高辛的相互作用及对睡眠和警觉性的影响。
J Clin Pharmacol. 1989 Jan;29(1):91-5. doi: 10.1002/j.1552-4604.1989.tb03243.x.
8
Determination of (E)-2,3-dichloro-4-methoxyphenyl)-2-furanylmethanone-O-[2-(diethylamino) ethyl]oxime methanesulphonate (ANP-4364) in plasma using gas chromatography with electron-capture detection.采用带电子捕获检测的气相色谱法测定血浆中(E)-2,3-二氯-4-甲氧基苯基)-2-呋喃基甲酮-O-[2-(二乙氨基)乙基]肟甲磺酸盐(ANP-4364)
J Chromatogr. 1979 May 11;173(1):147-54. doi: 10.1016/s0021-9673(01)80454-4.
9
Determination of 1,2-benzisoxazole-3-acetamidoxime hydrochloride (PE-257) in plasma using electron-capture gas chromatography.采用电子捕获气相色谱法测定血浆中的1,2-苯并异恶唑-3-乙酰氨基肟盐酸盐(PE-257)。
J Chromatogr. 1978 Mar 11;150(1):147-54. doi: 10.1016/s0021-9673(01)92106-5.
10
Sensitive one-step extraction procedure for column liquid chromatographic determination of fluvoxamine in human and rat plasma.用于柱液相色谱法测定人和大鼠血浆中氟伏沙明的灵敏一步提取程序。
J Chromatogr. 1991 Jul 5;567(2):441-9. doi: 10.1016/0378-4347(91)80150-b.

引用本文的文献

1
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的代谢与药代动力学
Cell Mol Neurobiol. 1999 Aug;19(4):443-66. doi: 10.1023/a:1006934807375.
2
Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的药代动力学-药效学关系
Clin Pharmacokinet. 1996 Dec;31(6):444-69. doi: 10.2165/00003088-199631060-00004.
3
Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration.
肝硬化患者单剂量口服马来酸氟伏沙明后的药代动力学
Clin Pharmacokinet. 1993 Feb;24(2):177-82. doi: 10.2165/00003088-199324020-00006.
4
A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.阿普唑仑与氟伏沙明联合给药的药代动力学和药效学评价。
Eur J Clin Pharmacol. 1994;46(1):35-9. doi: 10.1007/BF00195913.
5
Clinical pharmacokinetics of fluvoxamine.氟伏沙明的临床药代动力学。
Clin Pharmacokinet. 1994 Sep;27(3):175-90. doi: 10.2165/00003088-199427030-00002.
6
Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.氟伏沙明或锂盐长期治疗情感障碍患者期间的药物血浆水平及血小板5-羟色胺摄取抑制情况。
Br J Clin Pharmacol. 1983;15 Suppl 3(Suppl 3):365S-368S. doi: 10.1111/j.1365-2125.1983.tb02127.x.